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ABSTRACT
Objectives. The penetration of hydrocortisone (HC) from six topical over-the-counter products along with one
prescription cream through cultured normal human-derived epidermal keratinocytes (Epiderm™), mouse skin and
synthetic nylon membrane was performed as well as the effect hydrating the skin by pre-washing was explored using
the Upright Franz Cell.
Method and Results. Permeation of HC through EpiDerm™, mouse skin and synthetic membrane was highest with
the topical HC gel formulation with prewash treatment of the membranes among seven products evaluated,
198  32 mg/cm
2, 746.32  12.43 mg/cm
2, and 1882  395.18 mg/cm
2, respectively. Pre-washing to hydrate the skin
enhanced HC penetration through EpiDerm™ and mouse skin. The 24-hour HC released from topical gel with
prewash treatment was 198.495  32 mg/cm
2 and 746.32  12.43 mg/cm
2 while without prewash, the 24-h HC
released from topical gel was 67.2  7.41 mg/cm
2 and 653.43  85.62 mg/cm
2 though EpiDerm™ and mouse skin,
respectively. HC penetration through synthetic membrane was ten times greater than through mouse skin and
EpiDerm™. Generally, the shape, pattern, and rank order of HC diffusion from each commercial product was
similar through each membrane.
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Permeability
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Introduction
H
ydrocortisone (HC) has been applied topi-
cally to treat a variety of conditions due to its
anti-pruritic and anti-inﬂammatory properties
[1,2]. Several different membranes have been used
to study permeation of drug including synthetic
membranes [3], animal skin and human skin
donated from either cadaver or plastic surgery
[4–7]. Cellulose acetate membrane with 0.45 mm
pore size was one of several synthetic membranes
that have been used to determine the in vitro drug
release proﬁle of HC from creams, ointments, and
lotions using diffusion Franz cell system [3]. Cel-
lulose acetate with or without the wetting agent of
isopropyl myristate containing 15% ethoxylated
aliphatic amine had no signiﬁcant effect on HC
release from lotion and cream but signiﬁcantly
enhanced the release of HC from ointment [3].
The cumulative amount of HC released from
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portional to the square root of time or followed
Higuchi’s diffusion controlled model. The HC
release was faster from 2.5% compared to 1%
creams, which in turn was faster than from 0.5%
HC cream [3]. The release rate ranged between
0.61 and 2.68 mg/cm
2/min
0.5 for betamethsone
dipropionate depending on the percentage of
ethanol in the receptor medium [8]. Polysulfone
synthetic membrane was used to determine the
release rates from the corticosteroid ointments [9]
and yielded nearly identical release rates as the
mixed cellulose acetate/cellulose nitrate mem-
brane [10]. Shah’s observations were that the char-
acteristics of the membrane do not generally
contribute to release rate of HC from topical
dosage forms, provided that sufﬁcient porosity of
the membrane is maintained [8]. A novel topical
drug delivery vehicle of Span 20: Span 80 pronio-
somes showed an increase in diffusion of HC (1%)
through the skin (58.29%) [11]. The HC released
was linear to the square root of time.
Formulation of drug products for topical drug
administration is best assessed using a membrane
that is as similar as possible to human skin [12,13].
As there is limited availability of human skin and
securing and using animal skin has its own draw-
backs, cultured human epidermal keratinocytes
could possibly assist in formulation of topical drug
products. Normal human-derived epidermal kera-
tinocytes (NHEK, EpiDerm™) cultured to form a
multilayered, highly differentiated model of the
human epidermis is viable alternative. NHEK has
a well developed basement membrane, in vivo-like
lipid proﬁle and has been used in-vitro to assess
dermal irritancy and toxicology [14,15].
As NHEK is readily available this study was
performed to assess the usefulness of NHEK as a
permeation barrier. Three different membranes
(synthetic membrane, mouse skin and NHEK
(EpiDerm™)) were used to compare the diffusion
of HC from six OTC HC products and one pre-
scription HC product. A comparison of release
rates from the commercial HC products should
also allow better utility and use of the topical prod-
ucts in topical HC therapy.
Materials and Methods
Reagents and Standards
Hydrocortisone USP reference standard (Lot
20011), propylparaben USP reference standard
(Lot 130011) were obtained from USP (Rockville,
MD). Absolute—200 Proof Ethyl alcohol USP
was obtained from AAPER Alcohol and Chemical
Co. (Shelbyville, KY). HPLC-grade acetonitrile
and methanol were from EMD Chemicals, Inc.
(Gibbstown, NJ), FD&C Blue from Allied Chemi-
cal & Dye Co. (New York, NY).
Topical Hydrocortisone Products Studied
Six over-the-counter 1% HC products: one gel,
one ointment, one lotion and three creams were
evaluated, in addition to a prescription HC cream
USP, 2.5% (Table 1).
Synthetic Membrane, Mouse Skin and EpiDerm™
Cultured Human Skin
Forty-seven mm diameter, 0.45-mm porosity
Nylaﬂo nylon membrane ﬁlters, purchased from
Pall Life Science (Ann Arbor, MI) served as the
synthetic membrane. Mouse skin was provided as a
gift from Dr. Rong Cui (Oregon State University
College of Pharmacy). Immediately upon sacriﬁc-
ing the mice, the skin was excised. The skin was
cut into approximately 35-mm diameter ovals and
immediately mounted on the Franz cells for the
diffusion study after the hair and the subcutaneous
fat were removed. Twenty four normal human-
derived epidermal keranocytes (NHEK; Epi-
Derm™) cell cultured inserts were obtained four
separate times from MatTek (Ashland, MA).
NHEK cell culture inserts were immediately
mounted on the Franz cells for study within 1 hour
of an arrival. While NHEK cultured cells can be
refrigerated for four days and remain viable it is
Table 1 The studied formulations: 1 gel, 1 ointment, 1 lotion and 4 creams
Product name Dosage form Strength Packaging OTC or prescriptive Manufacturer
Cortaid Lotion 1% Pump bottle OTC Johnson & Johnson
Cortaid Cream 1% Plastic tube OTC Johnson & Johnson
Aveeno Cream 1% Plastic tube OTC Johnson & Johnson
Cortizone-10 Plus Cream 1% Plastic tube OTC Pﬁzer
Cortizon-10 Ointment 1% Plastic tube OTC Pﬁzer
Hydrocortisone Cream 2.5% Metal tube Prescriptive E. Fougera & Co
Corticool Gel 1% Plastic tube OTC Tec Labs
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results as storage conditions may be rigorous for
cells.
TransepidemalWaterlossTEWL (g/h/m
2)
The living tissue membranes (mouse skin and
NHEK) were tested for viability by the TEWL
test at time points 0 (the mouse skin was excised or
NHEK arrival) and at 10 and 24 hours after the
membranes were mounted on the Franz cells for
the diffusion studies.
The open chamber measurements were carried
out at normal room condition (20°C and 40–60%
air humidity) using Multi Probe Adapter MPA and
its probe- The Tewameter
®TM300 (CK electronic
GmbH, Mathias-Bruggen-Str.91 D-50829 Koln/
Germany) in Dr. Arup K. Indra’s laboratory
(Department of Pharmaceutical Sciences, College
of Pharmacy, Oregon State University).
HPLC Assay Development andValidation
The HPLC assay was adapted from HC cream
monograph, USP 33/NF28 (Rockville, MD). An
equal amount of acetonitrile was added to the col-
lected samples to precipitate protein prior to the
addition of the internal standard, propylparaben.
Filtered and degassed solution of water, methanol
and acetonitrile (61:19.5:19.5) was used as the
mobile phase to ensure separation of HC, internal
standard and unidentiﬁed peaks for all tested HC
products. The HC retention time was 22 minutes.
The HPLC system with autoinjector consisted of
aC 18 column (3.9 ¥ 150 mm, 5 m, Waters, Milford,
MA) with a precolumn (Model 590, Waters,
Milford, MA), a UV-VIS wavelength detector set
at 254 nm and an integrator recorder (Model 740
Data Module, Waters, Milford, MA). The injec-
tion volume was 50 mL. Flow rate of the pump was
1 mL/min. The standard curve was reproducible
and exhibited linearity in the range from 0.5 to
120 mg/mL.
InVitro Permeation Study
Synthetic Nylaﬂo, mouse skin and NHEK were
used as the barrier for the permeation study. The
effect of pre-washing skin for 30 sec prior to
applying HC products was also evaluated in order
to assess the effect of hydrating skin versus non-
hydrating skin with a surfactant solution on HC
diffusion. Also prewashing may remove a small
amount of the outer layer of the skin and affect
diffusion. While thickness of mouse skin and Epi-
derm™ was measured, no signiﬁcant differences
were observed.
The Upright Franz Cell (Crown Glass, Somer-
ville, NJ) consisted of 21 vertical cells (each with a
nominal diameter of 2.2 cm oriﬁce and a receiver
capacity of approximately 14 mL internal sample
receptor vessel volume with sampling port) and a
water bath (Forma Scientiﬁc, Marietta, OH) used
to maintain the temperature at 32  1°C. The
receiver chambers were ﬁlled with an aqueous
solution containing 25% ethyl alcohol and were
stirred at 300 rpm using a mini magnetic stirrer.
The entire surfaces of the mounted membranes
were in direct constant contact with the receiver
medium and the medium in receiver chambers was
maintained at temperature of 32  1°C. All the
membranes were pre-wetted in the aqueous recep-
tor medium for 15 minutes before use. A sample
specimen from each topical product was loaded
onto weighing paper and approximately 1 gram
weight of product cream, gel or ointment was
measured. After transferring the weighed material
of the topical product (the permeate) onto the
center of the pre-wetted membrane, the weighing
paper and permeate left on the weighing paper
were measured again to determine the exact
amount of permeate loaded on the membrane.
During membrane diffusion study, 150 mL aliquot
was taken from the sampling port at 0.5, 1.5, 3, 6,
10, 20 and 24 hours. After each sample was with-
drawn, the receptor medium was replenished with
150 mL of fresh medium. A 50 mL aliquot of the
collected sample was used in the HPLC assay. For
each diffusion test run in the study, a minimum of
three Franz diffusion cells were set up for each
topical product with each membrane and each HC
in vitro diffusion test was run in duplicate or trip-
licate with the gel formulation being run as many
as nine times (in Tables an n of 2 or 3 represents 6
or 9 individual cells).
Data Management
The release proﬁle of HC was determined over 24
hours and plotted based upon total amount of drug
loaded as cumulative amount of loaded drug
released versus time (Fick’s law) or square root of
time as suggested by Higuchi [3,16–18].
Commercial HC has melting point of 212–
213°C and solubility of 0.28 mg/mL in water,
15 mg/mL in alcohol, and 12.7 mg/mL in propy-
lene glycol at 25°C. The commercial gel product
was formulated as a clear solution of 10 mg/g.
For Fick’s law [19],
J
dM
Sdt
D
dC
dx
D
CC
h
== ⋅ = ⋅
− () 12 (1)
12 Christensen et al.
Arch Drug Info 2011;4:10–21dM
dt
DSKC
h
PSC
d
d == (2)
MP S Ct d =⋅ ⋅ ( )⋅ (3)
P
dM
dt
SC d
=
⋅
(4)
Where M is amount of drug (mg), J is ﬂux of drug
(mg/cm
2/hr), K is distribution or partition coefﬁ-
cient, S is unit cross section (cm
2) and P is perme-
ability coefﬁcient (cm/hr). dM
dt
is the ﬁtted release
rate of the HC release versus time proﬁle.
Higuchi developed an equation for the release
of a drug from an ointment base and later applied
it to diffusion of solid drugs dispersed in homoge-
neous and granular matrix systems and the amount
of drug depleted per unit area of the system, Q, at
time t, is given by the Higuchi equation [20]. This
equation, grounded on principles of diffusion as
expressed by Fick’s ﬁrst law of diffusion, describes
the release of a drug from topical dosage forms
such as gels, creams, and ointments.
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Where Q is the amount of drug depleted per unit
area of the matrix at time t (mg/cm
2), dQ/dt is the
rate of drug released per unit area of exposed
surface of the matrix,
D is the diffusion coefﬁcient of the drug in the
matrix (mg·mL/cm
4/hr),
Cd is the solubility of the drug in the homogeneous
matrix (formulation) (mg/cm
3), Cd = 1 mg/mL for
gel formulated as a solution within a clear gel. A is
the total concentration of dissolved and undis-
solved of the drug in the matrix (mg/cm
3).
After the HC release rate (mg/cm
2/hr
1/2) was
obtained from the diffusion proﬁle, the amount of
drug released per unit area (mg/cm
2) was plotted
against the square root of time and the diffusivity
or diffusion coefﬁcient, D, was calculated from Eq.
7 to assess the release proﬁle for HC from each
product. The total quantity for each topical for-
mulation placed on the membrane was measured
and was approximately 1 g for each Franz cell well.
The drug penetrating through the membranes to
the receiver chamber was analyzed by the HPLC
assay. The amount and the release rate over 24
hours was calculated with the assumption that the
theoretical maximum amount that can diffuse into
the donor chamber is 25 mg for the prescription
HC cream 2.5% and 10 mg for the 1% HC topical
formulations.
Statistics Method
To compare drug release behavior of all formula-
tions through “pre-wash” and “non-washed” skin,
simple paired t-tests were performed at 10, 20 and
24 hours on HC diffusion rates of the topical
products.
ANOVA for Multiple- linear regression method
was used to compare the release rates of HC gel
formulation to the other commercial formulations
[21]. A 95% conﬁdence interval band was set up
for HC diffusion proﬁle of gel formulation
through each membrane. If any speciﬁc point from
the amount released proﬁle for the other reference
formulations (ointments and creams) lies outside
the conﬁdence interval band of gel formulation
within the last four time points (6, 10, 20, 24
hours), the HC release proﬁle of gel formulation is
considered to be signiﬁcantly different from the
other topical formulations.
Results
Dissolution Proﬁles with Nylaﬂo Synthetic
Membrane Filters
The cumulative amount (mg/cm
2) of HC released
from the commercial products through synthetic
membrane was plotted against time and the square
root of time (hr
1/2) and are presented in Figure 1a
and b. The shape of the HC diffusion proﬁles was
approximately linear with respect to the square
root of time except from the gel formulation. The
release of HC at 24 hours was 1882.7  395 mg/
cm
2 for the gel formulation compared to 145–
200 mg/cm
2 for Cortaid creams. The diffusion
proﬁle of HC from the gel was signiﬁcantly
greater than other HC topical products with the
release of HC in 24 hours reaching
59.1%  3.92% which is as high as the Span 20:
Span 80 proniosome 1% HC formulation
(58.29%) [11]. The highest reported amount was
320 mg/cm
2 of HC released from HC lotion and
creams at 6 hours through cellulose acetate from a
2.5% lotion [3] which is comparable with the
Hydrocortisone Permeation 13
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2 HC
was released from gel formulation using Nyﬂon
membrane.
If the formulation is water-based, HC exists
mostly in suspension with a small amount dis-
solved in water, but the majority of the HC is
in solid form. Thus, without solubility enhancer,
the solubility (Cd) of HC is 0.28 mg/mL. If Cd
changes, the slope of the rate of drug diffusion
would change proportionally to the Cd value.
In the gel HC formulation used in this study,
the presence of propylene glycol and ethanol
increase the solubility of HC (solubility is
12.7 mg/mL and 15 mg/mL, respectively). The
use of these solvents in the gel formulation
allows all the HC to be in solution in the formu-
lation. The Cd of HC in the gel is 1 mg/mL and
causes an increase of the rate of diffusion through
the membrane as predicted by Fick’s law of
diffusion.
The permeability coefﬁcients of HC from all
formulations through the synthetic membrane
0.45 mm are showed in Table 2. The permeability
coefﬁcient of HC from the gel formulation taking
into consideration the high solubility of HC in the
gel is 7.8
*10
-3 cm/hour. The increase in HC solu-
bility accounts for most of the higher HC diffusion
rate.
Figure 1 (a) Hydrocortisone diffu-
sion proﬁle from topical formula-
tions over time through synthetic
membrane. = Cortisone-10 Oint-
ment,  = Cortisone-10 Plus
Cream;  = Cortaid Cream, :
Corticool gel ,  = Aveeno Cream,
 = Prescription HC Cream 2.5%,
: Cortaid lotion. (b) Diffusion
proﬁle of Hydrocortisone versus
the square root of time from formu-
lations through synthetic mem-
brane. = Cortisone-10 Ointment,
 = Cortisone-10 Plus Cream;
 = Cortaid Cream, : Corticool
gel ,  = Aveeno Cream,  = Pre-
scription HC Cream 2.5%, :
Cortaid lotion.
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Arch Drug Info 2011;4:10–21Ethyl alcohol and propylene glycol increases
skin penetration of drug. The presence of ethyl
alcohol and propylene glycol increased the solu-
bility of HC in the gel formulation and their com-
bined effects cause the permeability coefﬁcient of
HC from gel to be greater than in suspensions
(creams and lotions). The gel formulation is a
single phase with a high percentage of water.
Hydrocortisone inside the gel moves toward the
membrane according to its concentration gradi-
ent, and the concentration is maintained on the
surface of the membrane keeping the drug-release
rate high.
With regard to the diffusion of HC through the
synthetic membrane, the gel formulation had a
statistically signiﬁcant higher diffusion rate com-
pared to other formulations. The average drug
release from the gel formulation over 24 hours is
1895 (95% CI 1441–1950) mg/cm
2. The HC
release proﬁles for the other formulations fall
outside of the conﬁdence interval of gel formula-
tion over 24 hours. The 95% conﬁdence interval
predicted from linear regression of the drug
release proﬁles compared to the gel provide strong
evidence that drug diffusion through the mem-
brane from the gel formulation is superior to other
tested formulations.
TEWL Results
Stable, reproducible TEWL measurements were
reached. TEWL values at zero time point for all
the skin samples was 3.88  0.0632, or in the
range of values for very healthy skin conditions
(0–10). At time points 10 and 24 hours, the TEWL
obtained were in the range of 15–20 which showed
normal skin condition.
Permeation through Mouse Skin
The cumulative amount of HC released from the
commercial products against time and the square
rootoftime(hr
1/2)arepresentedinFigures 2and3:
a and b. The shapes of diffusion proﬁles are
approximatelylinearwithrespecttothesquareroot
of time with the release of HC at 24 hours being
over 650 mg/cm
2 for the gel and 50 to 160 mg/cm
2
forotherformulations.TheHCpermeabilityfrom
thegelwascalculatedinasimilarfashionformouse
skin as for the synthetic membrane with
Cd = 1 mg/mL for gel, Cd = 1 mg/mL for the oint-
ment and Cd = 0.28 mg/mL for the other formula-
tions. The permeability coefﬁcient of HC from the
gelisclosetothepermeabilitycoefﬁcientsobserved
for HC in the cream and the lotion. Previous
studies show that alcoholic vehicles are among
those reported to increase drug permeation[22].
Ethanol is primarily a lipid solvent that not only
increases lipid ﬂuidity within the intracellular
space, but also extends the hydrophobic domain
between the polar head groups in the stratum
corneum. As a result, ethanol and other enhancers
may change drug permeability. However, for HC
permeation from the gel, the effect of ethanol
appears to be negligible in comparison to the effect
that higher HC solubility produced.
Hydrocortisone ointment’s permeation proﬁle
and the release data of this formulation ﬁt to the
Higuchi model better; whereas the other formula-
tions ﬁt Fick’s law model of diffusion. Hydrocor-
tisone permeability coefﬁcients of all formulations
diffusing through non-prewashed mouse skin are
presented in Table 3.The diffusion coefﬁcients for
HC diffusing through non-prewashed mouse skin
determined using the Higuchi model are pre-
sented in Table 4.
Prewashed Mouse Skin Permeation
The HC diffusion proﬁles (amount permeation)
for the topical HC products are displayed in
Figure 3a and b. The values of HC permeability
coefﬁcients and diffusion coefﬁcients from each
topical product are presented in Tables 5 and 6.
All the formulations exhibited a signiﬁcantly
higher HC diffusion rates through the pre-washed
mouse skin compared to the non-prewashed
mouse skin (t-tests, P < 0.01). As mentioned pre-
viously, hydration of the skin usually results in an
increase in the drug diffusion rate through the skin
and water acts as a natural penetration enhancer.
An expected higher permeation of HC occurs with
hydrated mouse skin.
HC Permeation through NHEK (EpiDerm™)
Hydrocortisone diffusion proﬁles from seven for-
mulations through an Epiderm™ over 24 hours
Table 2 The permeability coefficients of hydrocortisone
for all formulations diffusing through the synthetic
membrane 0.45 mm
Formulation n
Permeability
coefficient
(cm/hr) R
2
Corticool gel* 10 7.8 * 10
-3 0.939
Cortizone-10 plus cream 5 2.555 * 10
-3 0.728
Cortaid cream 6 2.547 * 10
-3 0.875
Cortaid lotion 4 5.582 * 10
-3 0.944
Aveeno cream 4 2.253 * 10
-3 0.740
Prescription HC cream 2.5% 7 9.336 * 10
-3 0.939
*The permeability with solubility 1 mg/mL.
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Arch Drug Info 2011;4:10–21are presented in Figure 4a. The HC diffusion pro-
ﬁles from seven formulations plotted against the
square root of time through Epiderm™ over 24
hours are presented in Figure 4b.
The diffusion proﬁles for HC was appro-
ximately linear with respect to the square root
of time with the release of HC at 24 hours ranging
f r o m5t o5 2mg/cm
2 except for HC release from
the gel formulation. Both diffusion proﬁles of HC
permeation from the gel, with and without pre-
treatment wash, increased signiﬁcantly after ten
hours. The 24 hours HC release from gel was
67.20  7.41 mg/cm
2 without pretreatment and
198.46  32 mg/cm
2 with pretreatment wash.
The permeability coefﬁcients of HC from seven
topical formulations through NHEK and the dif-
fusion coefﬁcients of HC from seven formulations
using the Higuchi model are presented in Tables 7
and 8. The permeability and diffusion coefﬁcients
for HC from gel were greater than other formu-
lations. This can partially be explained by HC
solubility in the products. Hydrocortisone in the
gel is totally in solution while being in suspension
in other formulations. Hydrocortisone permeabil-
ity and diffusion-rate values for the gel formula-
tion were observed to be higher through the
prewashed mouse skin in comparison with non-
prewashed mouse skin (Table 9).
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Figure 2 (a) The diffusion proﬁle of
hydrocortisone versus time from for-
mulations through Non-prewashed
mouse skin. = Cortisone-10 Oint-
ment,  = Cortisone-10 Plus Cream;
 = Cortaid Cream, : Corticool
gel,  = Aveeno Cream,  = Pre-
scription HC Cream 2.5%, : Cortaid
lotion. (b). The diffusion of Hydrocor-
tisone versus the square root of
time proﬁle from formulations
through non-prewashed mouse skin.
= Cortisone-10 Ointment,
 = Cortisone-10 Plus Cream;
 = Cortaid Cream, : Corticool gel,
 = Aveeno Cream,  = Prescription
HC Cream 2.5%, : Cortaid lotion.
16 Christensen et al.
Arch Drug Info 2011;4:10–21Discussion
Percutaneous absorption data obtained in human
is most relevant for human exposure [12,13]. As
such, care must be taken in assessing in vitro
studies to assess the value they shed on dermato-
logical therapy. Still in vitro studies are valuable as
they can provide comparisons when as is included
here more than one commercial product is being
tested. The data presented here provides a reason-
able comparison to the commercial products and
sheds light on these products usefulness in therapy,
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Figure 3 (a) Diffusion of Hydrocorti-
sone versus time proﬁle from for-
mulations through the prewashed
mouse skin. = Cortisone-10 Oint-
ment,  = Cortisone-10 Plus Cream;
 = Cortaid Cream, : Corticool gel,
 = Aveeno Cream,  = Prescription
HC Cream 2.5%, : Cortaid lotion. (b)
Diffusion of Hydrocortisone versus
the square root of time proﬁle from
formulations through the prewashed
mouse skin. = Cortisone-10 Oint-
ment,  = Cortisone-10 Plus Cream;
 = Cortaid Cream, : Corticool gel,
 = Aveeno Cream,  = Prescription
HC Cream 2.5%, : Cortaid lotion.
Table 3 Hydrocortisone permeability coefficient and the
R
2 for linear ﬁtting of all formulations diffusing through
non-prewashed mouse skin
Formulation n
Permeability coefficient
(cm/hr) R
2
Corticool gel* 3 8.572 * 10
-3 0.998
Cortizone-10 plus cream
† 4 2.366 * 10
-3 0.862
Cortaid cream
† 5 2.138 * 10
-3 0.961
Cortaid lotion
† 3 1.326 * 10
-3 0.987
Cortizone-10 ointment* 3 2.419 * 10
-5 0.904
Aveeno cream
† 6 1.026 * 10
3 0.952
Prescription HC 2.5%
† 6 1.264 * 10
-3 0.916
*The permeability with solubility 1 mg/mL.
†The permeability with solubility 0.28 mg/mL.
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Arch Drug Info 2011;4:10–21an in vivo study with human subjects would yield
the most deﬁnitive conclusion for topical therapy.
Cultured human skin (NHEK) may be an alterna-
tive to use in routine testing of topical drug prod-
ucts for simulating topical skin permeation studies.
The 2.4 cm diameter NHEK cell culture insert
allows direct mounting onto the Upright Franz
Cell receptor chamber. Relatively, the shapes and
patterns of HC release proﬁles from cream, oint-
ment and gel commercial products were similar
between synthetic nylon membrane, mouse skin
and NHEK cultured human skin which was in the
agreement with Shah [8] regarding the type of
membranes used for topical drug release studies.
This suggests that drug formulation studies utiliz-
ing NHEK membrane are effective in discriminat-
ing between topical drug formulations and can be
used by the drug formulator as a membrane to
characterize formulation and excipient effects on
topical drug product performance.
In the present study, the HC gel formulation
released the highest cumulative amount of drug
through synthetic Nylon membrane (mg/cm
2), fol-
lowed by mouse skin and NHEK membrane. If the
Cd for HC solubility is 1 mg/mL instead of the
0.28 mg/mL in Eq. 7, the HC diffusion coefﬁcient
from gel is close to other formulations: two creams
and one lotion. Therefore, the high rate of HC
diffusion from the gel can primarily be explained
by the higher HC concentration gradient pro-
duced by the increased HC solubility between the
two sides of the membrane.
The ointment-diffusion proﬁle showed two
separate phases. A short initial phase lasting the
ﬁrst half hour displaying an initial high rate of the
drug’s diffusion of the HC in layers in the oint-
ment vehicle lying near the membrane. The HC
lying deeper inside the ointment matrix needs
to diffuse towards the membrane’s surface
before being able to diffuse through the barrier
Table 5 The diffusion coefficients of hydrocortisone from
eight formulations diffusing through pre-washed mouse skin
Formulation n
Permeability
coefficient
(cm/hr) R
2
Corticool gel * 3 3.22 * 10
-3 0.985
Cortizone-10 plus cream
† 4 1.261 * 10
-3 0.998
Cortaid cream
† 5 2.425 * 10
-3 0.964
Cortaid lotion
† 3 1.851 * 10
-3 0.998
Cortizone-10 ointment * 3 3.194 * 10
-5 0.904
Aveeno cream
† 6 2.479 * 10
3 0.998
Prescription HC 2.5%
† 6 1.877 * 10
-3 0.999
*The diffusion coefficient with solubility 1 mg/mL.
†The diffusion coefficient with solubility 0.28 mg/mL.
Table 6 The diffusion coefficients of hydrocortisone
through the pre-washed mouse skin for the topical
hydrocortisone formulations
Formulation n
Diffusion
coefficient
(cm
2/hr) R
2
Corticool gel 3 1.534 * 10
-3 0.982
Cortizone-10 plus cream 4 6.590 * 10
-5 0.909
Cortaid cream 5 9.669 * 10
-5 0.865
Cortaid lotion 3 6.558 * 10
-5 0.918
Cortizone-10 ointment 3 2.850 * 10
-7 0.934
Aveeno cream 6 2.111 * 10
-5 0.992
Prescription HC 2.5% 6 1.439 * 10
-5 0.982
Table 7 The permeability coefficients of hydrocortisone
from topical formulations diffusing through NHEK
(Epiderm™)
Formulation n
Permeability
coefficient
(cm/hr) R
2
Corticool gel w/o 3 1.012 * 10
-3 0.955
Cortizone-10 plus cream 3 6.366 * 10
-4 0.995
Cortaid cream 2 2.478 * 10
-4 0.904
Cortaid lotion 3 1.432 * 10
-4 0.880
Cortizone-10 ointment 3 2.546 * 10
-6 0.952
Prescription HC cream 2.5% 3 2.531 * 10
-4 0.939
Table 8 The diffusion coefficients of hydrocortisone for
topical commercial formulations diffusing through NHEK
using the Higuchi model
Formulation n
Diffusion
coefficients
(cm
2/hr) R
2
Corticool gel w/o 2 2.318 * 10
-5 0.848
Corticool gel w/w 1 1.987 * 10
-4 0.861
Cortizone-10 plus cream 3 5.057 * 10
-7 0.885
Cortaid cream 2 1.373 * 10
-6 0.791
Cortaid lotion 3 5.603 * 10
-7 0.947
Cortizone-10 ointment 3 1.969 * 10
-9 0.914
Prescription HC 2.5% 6 6.833 * 10
-6 0.658
Table 4 The diffusion coefficients for hydrocortisone
diffusing through non-pre-washed mouse skin from
commercial topical products following the Higuchi model
Formulation n
Diffusion
coefficient
(cm
2/hr) R
2
Corticool gel 3 3.465 * 10
-3 0.969
Cortizone-10 plus cream 4 1.478 * 10
-5 0.868
Cortaid cream 5 1.112 * 10
-5 0.949
Cortaid lotion 3 3.415 * 10
-5 0.977
Cortizone-10 ointment 3 8.477 * 10
-7 0.979
Aveeno cream 6 2.685 * 10
-5 0.832
Prescription HC 2.5% 6 3.336 * 10
-5 0.953
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cient and high viscosity of the ointment’s base
prevents HC from diffusing rapidly along its con-
centration gradient. The whole process is slower
and HC’s release rate decrease dramatically. The
second phase with the extremely low drug release
rate is the dominant phase for HC release from the
ointment.
Hydrocortisone diffusion through NHEK was
2.7 times greater from the gel formulation than the
other topical formulations. From ANOVA, no sig-
niﬁcant differences in HC release were noticed
among cream, lotion and ointment products;
however simple paired t-tests showed HC release
from gel and ointment to be different from the
creams and lotion as well as from each other. This
is likely due to low diffusion of HC through oint-
ment and HC being in solution in the gel formu-
lation whereas the cream and lotion formulations
are suspensions. Excluding the gel, the diffusion
rates of HC from the creams, and lotions through
the membranes are relatively consistent in this
study. However, one of the limitations of the study
was the small sample size and it is possible that if
more replications were performed the results may
differ. Hydrocortisone release proﬁle through
0.0
25.0
50.0
75.0
100.0
125.0
150.0
175.0
200.0
225.0
250.0
a
b
0 4 8 12 16 20 24
C
u
m
u
l
a
t
i
v
e
 
a
m
o
u
n
t
 
o
f
 
H
C
 
r
e
l
e
a
s
e
d
 
(
m
g
/
c
m
2
)
Time (hour)
0.0
25.0
50.0
75.0
100.0
125.0
150.0
175.0
200.0
225.0
250.0
012345
C
u
m
u
l
a
t
i
v
e
 
a
m
o
u
n
t
 
o
f
 
H
C
 
r
e
l
e
a
s
e
d
 
 
(
m
g
/
c
m
2
)
Time (hour1/2)
Figure 4 (a) Diffusion of Hydrocorti-
sone versus time proﬁle from formu-
lations through NHEK (Epiderm™)
over 24 hours. = Cortisone-10 Oint-
ment,  = Cortisone-10 Plus Cream;
 = Cortaid Cream, : Corticool gel,
 = Aveeno Cream,  = Prescription
HC Cream 2.5%, : Cortaid lotion.
(b). Diffusion of Hydrocortisone
versus the square root of time
proﬁle from formulations through
NHEK (Epiderm™) over 24 hours.
= Cortisone-10 Ointment,
 = Cortisone-10 Plus Cream;
 = Cortaid Cream, : Corticool gel,
 = Aveeno Cream,  = Prescription
HC Cream 2.5%, : Cortaid lotion.
Hydrocortisone Permeation 19
Arch Drug Info 2011;4:10–21NHEK culture cells yields excellent results that
are consistent with other membranes in providing
a discriminating tool that can be used to evaluate
HC permeation.
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